Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| APTARGROUP, INC.ATR · Entity 165 | Director · President and CEO | August 03, 2026 | August 04, 2026 |
| Ingredion IncINGR · Entity 3745 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
APTARGROUP, INC.
Report date August 03, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 238,729 |
Ending reported balance
After 2026-08-03 transaction · row 3
2 source rows · reconciled sequenceRow 2 · 2026-08-03 · Exercise / conversion · Acquired 9,838 · Balance 248,567 Row 3 · 2026-08-03 · Sale · Disposed 9,838 · Balance 238,729 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.0000 to $136.5200 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.79 · Expires 2027-02-10 | Direct | 0 |
Reported balance
After 2026-08-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-08-03 · Exercise / conversion · Disposed 9,838 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) trust | 3,150 |
Reported balance
Holding disclosure · report date 2026-08-03 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,150 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.0000 to $136.5200 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth.
Ingredion Inc
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,797 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 1,797 · Balance 1,797 F1: These are restricted stock units ("RSUs") issued under the Ingredion Incorporated Stock Incentive Plan to the Company's outside directors as part of their annual retainer (as further described in Exhibit 10.26 to the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 17, 2026). One portion of this grant covers the period from April 1, 2026 to May 19, 2026, and the remaining portion represents the full value of the outside directors' 2026 annual equity retainer, reflecting the Company's shift in 2026 from a calendar-year basis for director stock compensation to a twelve-month cycle aligned with the annual stockholder meeting. The RSUs may be settled only in shares of common stock (one share per RSU) and will vest on May 19, 2027, subject to the Committee's discretion to accelerate vesting upon an outside director's retirement, death, disability, or a Change in Control. |
| Common StockSEC Table I · non-derivative | Indirectthrough The Tanda Joint Living Trust | 10,737 |
Reported balance
Holding disclosure · report date 2026-05-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 10,737 |
Filing footnotes · ownership attribution and instrument terms
F1: These are restricted stock units ("RSUs") issued under the Ingredion Incorporated Stock Incentive Plan to the Company's outside directors as part of their annual retainer (as further described in Exhibit 10.26 to the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 17, 2026). One portion of this grant covers the period from April 1, 2026 to May 19, 2026, and the remaining portion represents the full value of the outside directors' 2026 annual equity retainer, reflecting the Company's shift in 2026 from a calendar-year basis for director stock compensation to a twelve-month cycle aligned with the annual stockholder meeting. The RSUs may be settled only in shares of common stock (one share per RSU) and will vest on May 19, 2027, subject to the Committee's discretion to accelerate vesting upon an outside director's retirement, death, disability, or a Change in Control.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Patheon N.V.
Report date August 29, 2017 · Filed August 30, 2017
Section 16 reporting ended · disclosed 2017-08-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (Ordinary Shares)SEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-29 transaction · row 1
1 source rowRow 1 · 2017-08-29 · Other · Disposed 4,659 · Balance 0 F1: Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was canceled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2) F2: upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3) F3: The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer. F4: This amount represents 4,659 restricted stock units, each of which represented a contingent right to receive one Share of Issuer. Each restricted stock unit was canceled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit upon the closing of the tender offer. |
Filing footnotes · ownership attribution and instrument terms
F1: Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was canceled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2)
F2: upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3)
F3: The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer.
F4: This amount represents 4,659 restricted stock units, each of which represented a contingent right to receive one Share of Issuer. Each restricted stock unit was canceled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit upon the closing of the tender offer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2026 Filed Aug 4, 2026 14:37 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionStock Option · Derivative | 9,838 | $0.00 Strike: $74.79 | $0.00 |
DisclosureSEC source: 0000896622-26-000172 · form4.xml · derivative · entry 4 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,838 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 14:37 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 9,838 | $136.16 | $1,339,588.32 |
DisclosureSEC source: 0000896622-26-000172 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,729 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.0000 to $136.5200 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 14:37 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionCommon Stock | 9,838 | $74.79 | $735,784.02 |
DisclosureSEC source: 0000896622-26-000172 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2026 Filed May 22, 2026 18:43 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 1,797 | $107.34 | $192,889.98 |
DisclosureSEC source: 0001046257-26-000192 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,797 F1 · shares: These are restricted stock units ("RSUs") issued under the Ingredion Incorporated Stock Incentive Plan to the Company's outside directors as part of their annual retainer (as further described in Exhibit 10.26 to the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 17, 2026). One portion of this grant covers the period from April 1, 2026 to May 19, 2026, and the remaining portion represents the full value of the outside directors' 2026 annual equity retainer, reflecting the Company's shift in 2026 from a calendar-year basis for director stock compensation to a twelve-month cycle aligned with the annual stockholder meeting. The RSUs may be settled only in shares of common stock (one share per RSU) and will vest on May 19, 2027, subject to the Committee's discretion to accelerate vesting upon an outside director's retirement, death, disability, or a Change in Control. Read SEC document |
| May 01, 2026 Filed May 4, 2026 23:58 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 15,538 | $119.02 | $1,849,332.76 |
DisclosureSEC source: 0000896622-26-000102 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,729 Read SEC document |
| May 01, 2026 Filed May 4, 2026 23:58 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 39,485 | $0.00 | $0.00 |
DisclosureSEC source: 0000896622-26-000102 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,267 Read SEC document |
| April 16, 2026 Filed Apr 16, 2026 18:26 UTC | Ingredion Inc INGR · Entity 3745 | GiftCommon Stock | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001046257-26-000165 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · through The Tanda Joint Living Trust Disclosed balance after: 10,737 F1 · balance_after: On April 16, 2026, the reporting person transferred 380 directly owned shares of Ingredion Incorporated common stock to The Tanda Joint Living Trust u/a/d 7/21/16, of which the insider and his spouse are the trustees and immediate family members are the beneficiaries. Read SEC document |
| April 16, 2026 Filed Apr 16, 2026 18:26 UTC | Ingredion Inc INGR · Entity 3745 | GiftCommon Stock | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001046257-26-000165 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| April 09, 2026 Filed Apr 13, 2026 23:36 UTC | Ingredion Inc INGR · Entity 3745 | GiftCommon Stock | 1,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001046257-26-000157 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · through The Tanda Joint Living Trust Disclosed balance after: 10,357 F1 · balance_after: On April 9, 2026, the reporting person transferred 1,557 directly owned shares of Ingredion Incorporated common stock to The Tanda Joint Living Trust u/a/d 7/21/16, of which the insider and his spouse are the trustees and immediate family members are the beneficiaries. Read SEC document |
| April 09, 2026 Filed Apr 13, 2026 23:36 UTC | Ingredion Inc INGR · Entity 3745 | GiftCommon Stock | 1,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001046257-26-000157 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380 Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:55 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 380 | $112.66 | $42,810.80 |
DisclosureSEC source: 0001046257-26-000141 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,937 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| March 19, 2026 Filed Mar 20, 2026 00:20 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantStock Option · Derivative | 53,691 | $0.00 Strike: $123.97 | $0.00 |
DisclosureSEC source: 0000896622-26-000083 · form4.xml · derivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,691 Underlying: Common Stock · 53,691 shares Expires 2036-03-19 F1 · derivative.exercise_date: The stock option vests in three equal installments beginning on the first anniversary of the grant date. Read SEC document |
| March 19, 2026 Filed Mar 20, 2026 00:20 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 13,796 | $0.00 | $0.00 |
DisclosureSEC source: 0000896622-26-000083 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,782 Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 21:28 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 1,772 | $129.50 | $229,474.00 |
DisclosureSEC source: 0000896622-26-000053 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,986 Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 18:21 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 3,455 | $128.65 | $444,485.75 |
DisclosureSEC source: 0000896622-26-000047 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,758 Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 23:07 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0000896622-26-000026 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,213 Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 23:07 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 940 | $142.68 | $134,119.20 |
DisclosureSEC source: 0000896622-26-000026 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,738 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 19:03 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 1,321 | $144.14 | $190,408.94 |
DisclosureSEC source: 0000896622-26-000020 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,678 Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 23:44 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 987 | $145.72 | $143,825.64 |
DisclosureSEC source: 0000896622-26-000014 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,999 Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 23:03 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 371 | $107.70 | $39,956.70 |
DisclosureSEC source: 0001046257-25-000146 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,557 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 16:45 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 321 | $124.49 | $39,961.29 |
DisclosureSEC source: 0001046257-25-000093 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,186 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 17:40 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 290 | $137.48 | $39,869.20 |
DisclosureSEC source: 0001127602-25-018550 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 865 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| May 07, 2025 Filed May 7, 2025 20:06 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionStock Option · Derivative | 17,771 | $0.00 Strike: $74.79 | $0.00 |
DisclosureSEC source: 0001062993-25-008755 · form4.xml · derivative · entry 8 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,838 Underlying: Common Stock · 17,771 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2025 Filed May 7, 2025 20:06 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 1,300 | $152.08 | $197,705.69 |
DisclosureSEC source: 0001062993-25-008755 · form4.xml · nonDerivative · entry 6 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,986 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.0000 to $152.1800 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| May 07, 2025 Filed May 7, 2025 20:06 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 16,471 | $151.18 | $2,490,008.37 |
DisclosureSEC source: 0001062993-25-008755 · form4.xml · nonDerivative · entry 5 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,286 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.9300 to $151.6600 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| May 07, 2025 Filed May 7, 2025 20:06 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionCommon Stock | 17,771 | $74.79 | $1,329,093.09 |
DisclosureSEC source: 0001062993-25-008755 · form4.xml · nonDerivative · entry 4 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2025 Filed May 7, 2025 20:06 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionStock Option · Derivative | 900 | $0.00 Strike: $74.79 | $0.00 |
DisclosureSEC source: 0001062993-25-008755 · form4.xml · derivative · entry 7 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,609 Underlying: Common Stock · 900 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2025 Filed May 7, 2025 20:06 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 900 | $152.03 | $136,830.96 |
DisclosureSEC source: 0001062993-25-008755 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,986 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.0300 to $152.0500 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| May 06, 2025 Filed May 7, 2025 20:06 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionCommon Stock | 900 | $74.79 | $67,311.00 |
DisclosureSEC source: 0001062993-25-008755 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2025 Filed May 6, 2025 19:12 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionStock Option · Derivative | 11,329 | $0.00 Strike: $74.79 | $0.00 |
DisclosureSEC source: 0001062993-25-008577 · form4.xml · derivative · entry 4 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,509 Underlying: Common Stock · 11,329 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2025 Filed May 6, 2025 19:12 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 11,329 | $152.39 | $1,726,422.91 |
DisclosureSEC source: 0001062993-25-008577 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,986 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.0000 to $152.9200 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| May 05, 2025 Filed May 6, 2025 19:12 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionCommon Stock | 11,329 | $74.79 | $847,295.91 |
DisclosureSEC source: 0001062993-25-008577 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2025 Filed May 6, 2025 15:23 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 17,968 | $152.00 | $2,731,136.00 |
DisclosureSEC source: 0001062993-25-008550 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,986 Read SEC document |
| May 02, 2025 Filed May 6, 2025 15:23 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 40,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-008550 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,954 Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:48 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 301 | $132.66 | $39,930.66 |
DisclosureSEC source: 0001127602-25-011158 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 575 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 22:51 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantStock Option · Derivative | 45,557 | $0.00 Strike: $147.84 | $0.00 |
DisclosureSEC source: 0001062993-25-005814 · form4.xml · derivative · entry 4 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,557 Underlying: Common Stock · 45,557 shares Expires 2035-03-17 F1 · derivative.exercise_date: The stock option vests in three equal installments beginning on the first anniversary of the grant date. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 22:51 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 11,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005814 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,398 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 22:51 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 3,454 | $147.84 | $510,639.36 |
DisclosureSEC source: 0001062993-25-005814 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,400 Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 22:09 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 2,783 | $146.66 | $408,154.78 |
DisclosureSEC source: 0001062993-25-005615 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,854 Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 19:33 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 6,361 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003602 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,637 Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 19:33 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 1,535 | $147.71 | $226,734.85 |
DisclosureSEC source: 0001062993-25-003602 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,276 Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 19:48 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 2,307 | $145.61 | $335,922.27 |
DisclosureSEC source: 0001062993-25-003397 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,811 Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 19:23 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 274 | $145.55 | $39,880.70 |
DisclosureSEC source: 0001127602-24-029316 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| October 28, 2024 Filed Oct 28, 2024 19:25 UTC | Ingredion Inc INGR · Entity 3745 | GiftCommon Stock | 2,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-026019 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · through The Tanda Joint Living Trust Disclosed balance after: 8,800 F1 · balance_after: On October 28, 2024, the reporting person?transferred 2,454 directly owned shares of Ingredion Incorporated common stock to The?Tanda?Joint Living Trust u/a/d 7/21/16 of which the insider?and his spouse are the trustees and immediate family members are the beneficiaires. Read SEC document |
| October 28, 2024 Filed Oct 28, 2024 19:25 UTC | Ingredion Inc INGR · Entity 3745 | GiftCommon Stock | 2,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-026019 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| October 28, 2024 Filed Oct 29, 2024 17:13 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $74.79 | $0.00 |
DisclosureSEC source: 0001062993-24-018065 · form4.xml · derivative · entry 6 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,838 Underlying: Common Stock · 30,000 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2024 Filed Oct 29, 2024 17:13 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 818 | $170.91 | $139,804.13 |
DisclosureSEC source: 0001062993-24-018065 · form4.xml · nonDerivative · entry 5 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,118 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.7700 to $171.0100 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| October 28, 2024 Filed Oct 29, 2024 17:13 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 7,060 | $170.22 | $1,201,734.84 |
DisclosureSEC source: 0001062993-24-018065 · form4.xml · nonDerivative · entry 4 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,936 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.7700 to $170.7500 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| October 28, 2024 Filed Oct 29, 2024 17:13 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 22,122 | $169.36 | $3,746,577.50 |
DisclosureSEC source: 0001062993-24-018065 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,996 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.7600 to $169.7400 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| October 28, 2024 Filed Oct 29, 2024 17:13 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionCommon Stock | 30,000 | $74.79 | $2,243,700.00 |
DisclosureSEC source: 0001062993-24-018065 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.